Adacotech is a biotech company that develops AI technologies and solutions for genomic analysis, biomarker discovery, and diagnostic apps.
Adacotech has raised $8.6M in total funding. The most recent round was Series B. The last funding was announced in April 2022.
Adacotech's investors include UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, DNX Ventures, Spiral Capital, FinTech Global.
Adacotech is headquartered in Tokyo, Japan.
Adacotech is a biotech company that develops AI technologies and solutions for genomic analysis, biomarker discovery, and diagnostic apps.
Adacotech is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adacotech — Funding & Investors." VCBacked, April 27, 2022, https://www.vcbacked.co/company/adacotech. Accessed September 29, 2026.
VCBacked. (2022). Adacotech — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/adacotech
{{cite web |title=Adacotech — Funding & Investors |url=https://www.vcbacked.co/company/adacotech |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated